Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Matsui

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Journal of Neurochemistry|April 9, 2005
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stabilityFan-Yan Wei, Kazuhito Tomizawa, Toshio Ohshima, et al.
Scientific Reports|March 19, 2016
Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerizationKeiichiro Hayashi, Hiroyuki Michiue, Hiroshi Yamada, et al.
The Journal of Cell Biology|November 19, 2003
Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesiclesKazuhito Tomizawa, Satoshi Sunada, Yun-Fei Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesotheliomaTakafumi Kubo, Shinichi Toyooka, Kazunori Tsukuda, et al.
Cell Metabolism|March 5, 2015
Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humansFan-Yan Wei, Bo Zhou, Takeo Suzuki, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
Journal of Medicinal Chemistry|November 15, 2011
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's diseaseHideaki Matsui, Shinji Ito, Hideki Matsui, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Journal of Neurochemistry|April 9, 2005
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stabilityFan-Yan Wei, Kazuhito Tomizawa, Toshio Ohshima, et al.
Scientific Reports|March 19, 2016
Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerizationKeiichiro Hayashi, Hiroyuki Michiue, Hiroshi Yamada, et al.
The Journal of Cell Biology|November 19, 2003
Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesiclesKazuhito Tomizawa, Satoshi Sunada, Yun-Fei Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesotheliomaTakafumi Kubo, Shinichi Toyooka, Kazunori Tsukuda, et al.
Cell Metabolism|March 5, 2015
Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humansFan-Yan Wei, Bo Zhou, Takeo Suzuki, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
Journal of Medicinal Chemistry|November 15, 2011
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's diseaseHideaki Matsui, Shinji Ito, Hideki Matsui, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
Pageof 11